Cargando…

A Description of the Type, Frequency and Severity of Infections Among Sixteen Patients Treated for T-Cell Lymphoma

BACKGROUND: Infections are an important cause of morbidity and mortality in T-cell lymphomas. Factors contributing to increased risk of infection include the nature of the underlying disease, as well as treatment-associated immunosuppression. Currently there are few reports describing the types of i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ko, Tina, Seah, Crystal, Gilbertson, Michael, McQuilten, Zoe, Opat, Stephen, Dendle, Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256920/
https://www.ncbi.nlm.nih.gov/pubmed/34267849
http://dx.doi.org/10.14740/jh838
_version_ 1783718195386908672
author Ko, Tina
Seah, Crystal
Gilbertson, Michael
McQuilten, Zoe
Opat, Stephen
Dendle, Claire
author_facet Ko, Tina
Seah, Crystal
Gilbertson, Michael
McQuilten, Zoe
Opat, Stephen
Dendle, Claire
author_sort Ko, Tina
collection PubMed
description BACKGROUND: Infections are an important cause of morbidity and mortality in T-cell lymphomas. Factors contributing to increased risk of infection include the nature of the underlying disease, as well as treatment-associated immunosuppression. Currently there are few reports describing the types of infections, including preventable infections, in this cohort of patients. The aim of the study was to identify the type, frequency and severity of infection in patients with T-cell lymphoma undergoing treatment. METHODS: A case series was performed on all patients with T-cell lymphoma over a 5-year period from 2011 to 2016 at a tertiary Australian hospital. Information was collected from medical record review regarding patient demographics, lymphoma treatment and outcomes, and infectious outcomes. Severe infections were recorded, defined as infection requiring hospitalization. RESULTS: Sixteen patients were identified with a diagnosis of T-cell lymphoma who received treatment at our institution. There were 42 discrete episodes of severe infections in total. Severe infections occurred in 81% of patients, with over 40% having more than one infection. The median length of hospital stay was 13 days, 33% required intensive care admission and 14% of infectious episodes resulted in death. Only 50% of infectious episodes were microbiologically proven, with the most common etiology being bacterial. The most commonly isolated organism overall was Staphylococcus aureus, with the most common source of infection being skin and soft tissue. There was one case of cytomegalovirus (CMV) infection and five cases (12%) of invasive fungal infection. The highest rates of infection occurred during progressive disease. Rates of prophylaxis were highest with antiviral agents, and comparatively lower with antibacterial and antifungal agents. CONCLUSION: Infections are frequent, opportunistic and severe in patients with T-cell lymphoma. Our data suggests that fungal prophylaxis may be indicated with T-cell lymphoma.
format Online
Article
Text
id pubmed-8256920
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-82569202021-07-14 A Description of the Type, Frequency and Severity of Infections Among Sixteen Patients Treated for T-Cell Lymphoma Ko, Tina Seah, Crystal Gilbertson, Michael McQuilten, Zoe Opat, Stephen Dendle, Claire J Hematol Short Communication BACKGROUND: Infections are an important cause of morbidity and mortality in T-cell lymphomas. Factors contributing to increased risk of infection include the nature of the underlying disease, as well as treatment-associated immunosuppression. Currently there are few reports describing the types of infections, including preventable infections, in this cohort of patients. The aim of the study was to identify the type, frequency and severity of infection in patients with T-cell lymphoma undergoing treatment. METHODS: A case series was performed on all patients with T-cell lymphoma over a 5-year period from 2011 to 2016 at a tertiary Australian hospital. Information was collected from medical record review regarding patient demographics, lymphoma treatment and outcomes, and infectious outcomes. Severe infections were recorded, defined as infection requiring hospitalization. RESULTS: Sixteen patients were identified with a diagnosis of T-cell lymphoma who received treatment at our institution. There were 42 discrete episodes of severe infections in total. Severe infections occurred in 81% of patients, with over 40% having more than one infection. The median length of hospital stay was 13 days, 33% required intensive care admission and 14% of infectious episodes resulted in death. Only 50% of infectious episodes were microbiologically proven, with the most common etiology being bacterial. The most commonly isolated organism overall was Staphylococcus aureus, with the most common source of infection being skin and soft tissue. There was one case of cytomegalovirus (CMV) infection and five cases (12%) of invasive fungal infection. The highest rates of infection occurred during progressive disease. Rates of prophylaxis were highest with antiviral agents, and comparatively lower with antibacterial and antifungal agents. CONCLUSION: Infections are frequent, opportunistic and severe in patients with T-cell lymphoma. Our data suggests that fungal prophylaxis may be indicated with T-cell lymphoma. Elmer Press 2021-06 2021-06-16 /pmc/articles/PMC8256920/ /pubmed/34267849 http://dx.doi.org/10.14740/jh838 Text en Copyright 2021, Ko et al. https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communication
Ko, Tina
Seah, Crystal
Gilbertson, Michael
McQuilten, Zoe
Opat, Stephen
Dendle, Claire
A Description of the Type, Frequency and Severity of Infections Among Sixteen Patients Treated for T-Cell Lymphoma
title A Description of the Type, Frequency and Severity of Infections Among Sixteen Patients Treated for T-Cell Lymphoma
title_full A Description of the Type, Frequency and Severity of Infections Among Sixteen Patients Treated for T-Cell Lymphoma
title_fullStr A Description of the Type, Frequency and Severity of Infections Among Sixteen Patients Treated for T-Cell Lymphoma
title_full_unstemmed A Description of the Type, Frequency and Severity of Infections Among Sixteen Patients Treated for T-Cell Lymphoma
title_short A Description of the Type, Frequency and Severity of Infections Among Sixteen Patients Treated for T-Cell Lymphoma
title_sort description of the type, frequency and severity of infections among sixteen patients treated for t-cell lymphoma
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256920/
https://www.ncbi.nlm.nih.gov/pubmed/34267849
http://dx.doi.org/10.14740/jh838
work_keys_str_mv AT kotina adescriptionofthetypefrequencyandseverityofinfectionsamongsixteenpatientstreatedfortcelllymphoma
AT seahcrystal adescriptionofthetypefrequencyandseverityofinfectionsamongsixteenpatientstreatedfortcelllymphoma
AT gilbertsonmichael adescriptionofthetypefrequencyandseverityofinfectionsamongsixteenpatientstreatedfortcelllymphoma
AT mcquiltenzoe adescriptionofthetypefrequencyandseverityofinfectionsamongsixteenpatientstreatedfortcelllymphoma
AT opatstephen adescriptionofthetypefrequencyandseverityofinfectionsamongsixteenpatientstreatedfortcelllymphoma
AT dendleclaire adescriptionofthetypefrequencyandseverityofinfectionsamongsixteenpatientstreatedfortcelllymphoma
AT kotina descriptionofthetypefrequencyandseverityofinfectionsamongsixteenpatientstreatedfortcelllymphoma
AT seahcrystal descriptionofthetypefrequencyandseverityofinfectionsamongsixteenpatientstreatedfortcelllymphoma
AT gilbertsonmichael descriptionofthetypefrequencyandseverityofinfectionsamongsixteenpatientstreatedfortcelllymphoma
AT mcquiltenzoe descriptionofthetypefrequencyandseverityofinfectionsamongsixteenpatientstreatedfortcelllymphoma
AT opatstephen descriptionofthetypefrequencyandseverityofinfectionsamongsixteenpatientstreatedfortcelllymphoma
AT dendleclaire descriptionofthetypefrequencyandseverityofinfectionsamongsixteenpatientstreatedfortcelllymphoma